LPL Financial
SLS icon

LPL Financial’s SELLAS Life Sciences SLS Stock Holding History

LPL Financial’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Buy
155,663
+18,455
+13% +$127K ﹤0.01% 3606
2026
Q1 		$580K Buy
137,208
+40,903
+42% +$183K ﹤0.01% 4631
2025
Q4 		$363K Buy
96,305
+25,266
+36% +$49.1K ﹤0.01% 4995
2025
Q3 		$114K Buy
71,039
+3,479
+5% +$6.2K ﹤0.01% 5482
2025
Q2 		$148K Buy
67,560
+1,816
+3% +$2.79K ﹤0.01% 5177
2025
Q1 		$71K Buy
65,744
+13,850
+27% +$16.4K ﹤0.01% 5102
2024
Q4 		$54K Hold
51,894
– – ﹤0.01% 5095
2024
Q3 		$64.9K Hold
51,894
– – ﹤0.01% 4962
2024
Q2 		$61.8K Buy
+51,894
New +$70.6K ﹤0.01% 4816

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

LPL Financial's SLS Position: Q2 2026 in Review

LPL Financial increased its SELLAS Life Sciences (SLS) stake by 13% in Q2 2026, buying an estimated $127K and bringing the position to 155,663 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

LPL Financial first reported a position in SLS in Q2 2024 and has held it in 9 quarters since. 84 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • LPL Financial held 155,663 shares of SELLAS Life Sciences worth $2.3M as of Q2 2026.
  • LPL Financial bought 18,455 SELLAS Life Sciences shares in Q2 2026, an estimated $127K.
  • SELLAS Life Sciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3606 holding.
  • LPL Financial first reported a position in SELLAS Life Sciences in Q2 2024 and has held it in 9 quarters since.
  • 84 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.